<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">IL-17A (-197G/A) and IL-17F (7488T/C) gene polymorphisms and cancer risk in Asian population: a meta-analysis</title>
			</titleStmt>
			<publicationStmt>
				<publisher>Dove Medical Press Ltd.</publisher>
				<availability status="unknown"><p>Copyright Dove Medical Press Ltd.</p>
				</availability>
				<date type="published" when="2014-05-13">13 May 2014</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wei</forename><surname>Dai</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Oromaxillofacial, Head and Neck Surgery</orgName>
								<orgName type="department" key="dep2">Department of Oral and Maxillofacial Surgery</orgName>
								<orgName type="department" key="dep3">School of Stomatology</orgName>
								<orgName type="institution">China Medical University</orgName>
								<address>
									<settlement>Shenyang</settlement>
									<country>People&apos;s Republic of China</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Oromaxillofacial, Head and Neck Surgery</orgName>
								<orgName type="department" key="dep2">Department of Oral and Maxillofacial Surgery</orgName>
								<orgName type="department" key="dep3">Medical University</orgName>
								<address>
									<addrLine>Nanjing Street, No 117, Heping District</addrLine>
									<postCode>110002</postCode>
									<settlement>Shenyang</settlement>
									<country>China, People&apos;s Republic of China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Qing</forename><surname>Zhou</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Oromaxillofacial, Head and Neck Surgery</orgName>
								<orgName type="department" key="dep2">Department of Oral and Maxillofacial Surgery</orgName>
								<orgName type="department" key="dep3">School of Stomatology</orgName>
								<orgName type="institution">China Medical University</orgName>
								<address>
									<settlement>Shenyang</settlement>
									<country>People&apos;s Republic of China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xuexin</forename><surname>Tan</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Oromaxillofacial, Head and Neck Surgery</orgName>
								<orgName type="department" key="dep2">Department of Oral and Maxillofacial Surgery</orgName>
								<orgName type="department" key="dep3">School of Stomatology</orgName>
								<orgName type="institution">China Medical University</orgName>
								<address>
									<settlement>Shenyang</settlement>
									<country>People&apos;s Republic of China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Changfu</forename><surname>Sun</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Oromaxillofacial, Head and Neck Surgery</orgName>
								<orgName type="department" key="dep2">Department of Oral and Maxillofacial Surgery</orgName>
								<orgName type="department" key="dep3">School of Stomatology</orgName>
								<orgName type="institution">China Medical University</orgName>
								<address>
									<settlement>Shenyang</settlement>
									<country>People&apos;s Republic of China</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">IL-17A (-197G/A) and IL-17F (7488T/C) gene polymorphisms and cancer risk in Asian population: a meta-analysis</title>
					</analytic>
					<monogr>
						<title level="j" type="main">OncoTargets and Therapy</title>
						<title level="j" type="abbrev">OTT</title>
						<idno type="eISSN">1178-6930</idno>
						<imprint>
							<publisher>Dove Medical Press Ltd.</publisher>
							<biblScope unit="page">703</biblScope>
							<date type="published" when="2014-05-13">13 May 2014</date>
						</imprint>
					</monogr>
					<idno type="DOI">10.2147/ott.s62781</idno>
					<idno type="PMID">24868166</idno>
					<idno type="PMCID">PMC4027853</idno>
					<ptr type="open-access" target="https://www.dovepress.com/getfile.php?fileID=20014" />
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-14T00:14+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>interleukin-17</term>
					<term>meta-analysis</term>
					<term>cancer</term>
					<term>polymprphism</term>
				</keywords>
			</textClass>
			<abstract>
				<p>Interleukin (IL)-17 has been shown to play an important role in the pathogenesis of inflammation and cancer. The IL-17A (-197G/A) and IL-17F (7488T/C) polymorphisms have been extensively investigated with cancer risk, but individually published results have been inconclusive. The aim of this study was to clarify the effects of the IL-17A (-197G/A) and IL-17F (7488T/C) polymorphisms on cancer risk in Asian populations. Relevant studies were identified by searching databases extensively. The association between the IL-17A (-197G/A) and IL-17F (7488T/C) polymorphisms and cancer risk was assessed by odds ratios (ORs) together with their 95% confidence intervals (CIs). A total of 12 articles with adequate information satisfied our inclusion criteria; these included 12 studies, with 4,540 cases and 5,875 controls, of IL-17A (-197G/A) polymorphism and seven studies, with 1,960 cases and 3,226 controls, of IL-17F (7488T/C) polymorphism. In the overall analysis, the IL-17A (-197G/A) polymorphism was significantly associated with increased cancer risk (P,0.05), for all genetic models. However, there was no statistically significant association between IL-17F (7488T/C) and cancer risk (P.0.05), for any genetic models. Furthermore, stratification by cancer type revealed a significant correlation between the IL-17A (-197G/A) polymorphism and cancer risk for all cancer types. When stratified by source of controls, a significant correlation was observed between the IL-17A (-197G/A) polymorphism and cancer risk in the populationbased control subgroup but not in hospital-based control subgroup. In conclusion, our metaanalysis provides evidence that the IL-17A (-197G/A) polymorphism might be associated with cancer risk, while no evidence suggested a significant association between IL-17F (7488T/C) polymorphism and cancer risk.</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p>Interleukin (IL)-17A, initially termed as cytotoxic T lymphocyte-associated antigen (CTLA)-8, is the founding member of IL-17 cytokine family, consisting of six homologous proteins (from IL-17A to IL-17F). <ref type="bibr" target="#b0">1</ref> IL-17 is a pleiotropic cytokine that acts on multiple cell types to enhance the production of proinflammatory molecules, including the induction of IL-6, IL-8, and prostaglandin E 2 , as well as enhancing granulocyte colony-stimulating factor and CXC chemokine production. <ref type="bibr" target="#b1">2,</ref><ref type="bibr" target="#b2">3</ref> In addition, IL-17 induces secretion of tumor necrosis factor (TNF)-α, IL-1β, and stromelysin, by macrophages, <ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b4">5</ref> and activates the nuclear factor κB and activator protein 1 transcription factors, which may explain its proinflammatory properties. <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b6">7</ref> Recently, several studies have shown that IL-17 can have either a protumor or antitumor role in different cancer models. <ref type="bibr" target="#b7">8</ref> Accumulating evidence indicates that IL-17 expression is aberrant in several human tumors, such as ovarian cancer, <ref type="bibr" target="#b8">9</ref> cervical cancer, <ref type="bibr" target="#b9">10</ref> breast cancer, <ref type="bibr" target="#b10">11</ref> hepatocellular carcinoma, <ref type="bibr" target="#b11">12</ref> esophageal cancer, <ref type="bibr" target="#b12">13</ref> gastric cancer, <ref type="bibr" target="#b13">14</ref> and colorectal cancer. <ref type="bibr" target="#b14">15</ref> But the underlying mechanism of IL-17 in tumor initiation and progression is not yet completely clear. Of note, Kryczek et al suggested that endogenous IL-17 or/and T helper (Th)17 cells may play a protective role in tumor immunity. <ref type="bibr" target="#b15">16</ref> Martin-Orozco et al reported that IL-17A-deficient mice were more susceptible to developing lung melanoma. <ref type="bibr" target="#b16">17</ref> These studies showed an opposite role of IL-17; specifically, they suggest an antitumor effect, by promoting cytotoxic T lymphocyte generation.</p><p>A large number of previous studies have suggested the possible correlation between genetic polymorphisms of cancer susceptibility genes and higher risk of human malignant tumors. There are several single nucleotide polymorphisms (SNPs) that are reported for the IL-17 gene, and the IL-17A gene polymorphism IL-17A (-197G/A, rs2275913) and IL-17F gene polymorphism IL-17F (7488T/C, rs763780) are reported to be associated in gastric carcinogenesis. <ref type="bibr" target="#b17">18</ref> IL-17A (-197G/A), located at a position -197 from the starting codon of the IL-17A gene, may regulate the expression of messenger ribonucleic acid (mRNA). <ref type="bibr" target="#b18">19</ref> Recently, Kawaguchi et al reported that IL-17F (7488T/C) causes a histidine (His)-to-arginine (Arg) substitution at amino acid 161 (H161R) variant. <ref type="bibr" target="#b19">20</ref> To date, many studies have been published that assessed the association between the IL-17A (-197G/A) and IL-17F (7488T/C) polymorphisms and cancer susceptibility, but they have reported controversial results. A single case-control study may fail to completely demonstrate the complicated genetic relationship because of the small sample size. <ref type="bibr" target="#b20">21</ref> In order to provide strong evidence of the effects of the IL-17A (-197G/A) and IL-17F (7488T/C) polymorphisms on cancer susceptibility, we performed a meta-analysis, by combining data from numerous published studies.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Search strategy</head><p>A comprehensive literature search of PubMed, Embase, Web of Science, Science Direct, SpringerLink, and the Chinese National Knowledge Infrastructure databases (up to November 2013) was conducted to identify casecontrol studies that investigated the association between IL-17 polymorphisms and cancer risk. The search strategies were based on combinations of the following keywords: "cancer or carcinoma or neoplasm or tumor" AND "IL-17 or IL-17A or IL-17F or CTLA" AND "polymorphism or variant or mutation or genotype". There was no restriction on time period, sample size, population, or language, in order to minimize potential publication bias.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Selection criteria</head><p>Studies were included in the meta-analysis if they satisfied the following inclusion criteria: 1) case-control studies focused on association between the IL-17A (-197G/A) or IL-17F (7844T/C) polymorphism and cancer risk; 2) study design that was either retrospective or a nested case-control design; 3) any diagnoses of patients with cancer had to be confirmed by pathological examinations; and 4) sufficient published data to estimate the odds ratio (OR) and corresponding 95% confidence interval (CI). The exclusion criteria of the meta-analysis were: 1) case-control studies not focusing on the correlation between the IL-17A (-197G/A) or IL-17F (7844T/C) polymorphism and cancer risk; 2) studies with duplicate data; 3) studies with incomplete data; and 4) meta-analyses, letters, reviews, and editorial articles. When an individual author published several articles obtained from the same patient population, only the newest or most complete article was included in the analysis.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Data extraction</head><p>Two authors independently extracted data from the included studies (Dai and Zhou). For each eligible study, the following information was extracted: first author's name, year of publication, country, ethnicity, cancer type, numbers of cases and controls, source of controls (hospital-based controls or population-based controls), genotyping method, and the Hardy-Weinberg equilibrium frequency. In cases of discrepancy, a consensus was reached by consulting a third author.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Sensitivity analysis</head><p>Sensitivity analysis was employed by sequentially excluding a single study each time, in an attempt to identify the potential influence of the individual data set to the pooled ORs. <ref type="bibr" target="#b21">22</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p>Data management and processing were performed using Review Manager (RevMan) <ref type="bibr" target="#b4">5</ref>  (MM vs WM + WW), homozygote comparison (MM vs WW), and heterozygote comparison (WM vs WW), respectively. Stratified analyses were conducted with respect to cancer type and source of controls. Statistical heterogeneity among the studies was evaluated using the chi square-based Q-test, and heterogeneity was considered significant when P,0.1 for Q statistic. Heterogeneity was quantified by I2 statistics examining the percentage of heterogeneity (0%-25% = no heterogeneity; 25%-50% = moderate heterogeneity; 50%-75% = large heterogeneity; and 75%-100% = extreme heterogeneity). <ref type="bibr" target="#b22">23</ref> The random effects model was used when heterogeneity was significant (I 2 .50% or P#0.10); otherwise, the fixed effects model was used. Publication bias was examined with both Begg's funnel plot <ref type="bibr" target="#b23">24</ref> and the Egger's regression method, <ref type="bibr" target="#b24">25</ref> and P,0.05 was considered representative of statistically significant publication bias.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Characteristics of eligible studies</head><p>A total of 136 relevant studies were reviewed based on our selection strategy. The stepwise selection process is shown in <ref type="figure" target="#fig_0">Figure 1</ref>. After sequential selection, a total of 12 articles with adequate information satisfied our inclusion criteria, among which were 12 studies, with 4,540 cases and 5,875 controls, of the IL-17A (-197G/A) polymorphism <ref type="bibr" target="#b17">18,</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref><ref type="bibr" target="#b30">[31]</ref><ref type="bibr" target="#b31">[32]</ref><ref type="bibr" target="#b32">[33]</ref><ref type="bibr" target="#b33">[34]</ref><ref type="bibr" target="#b34">[35]</ref><ref type="bibr" target="#b35">[36]</ref> and seven studies, with 1,960 cases and 3,226 controls, of the IL-17F (7488T/C) polymorphism <ref type="bibr" target="#b17">18,</ref><ref type="bibr" target="#b28">29,</ref><ref type="bibr" target="#b30">[31]</ref><ref type="bibr" target="#b31">[32]</ref><ref type="bibr" target="#b32">[33]</ref><ref type="bibr" target="#b33">[34]</ref><ref type="bibr" target="#b35">36</ref> All studies were case-control designs, with subjects of Asian ancestry. Out of the 12 applicable studies, eight were studies of gastric cancer, one was cervical cancer, one was breast cancer, one was ovarian cancer, and one was bladder cancer. Populationbased controls were used in seven studies, and hospital-based controls were used in five studies. The detailed characteristics of the eligible studies are listed in <ref type="table" target="#tab_3">Table 1</ref>. The genotype distribution of IL-17 polymorphisms in the controls was in compliance with Hardy-Weinberg equilibrium, except for two studies of IL-17A (-197G/A) polymorphism <ref type="bibr" target="#b17">18,</ref><ref type="bibr" target="#b33">34</ref> and three studies of IL-17F (7488T/C) polymorphism. <ref type="bibr" target="#b29">30,</ref><ref type="bibr" target="#b31">32,</ref><ref type="bibr" target="#b32">33</ref> Quantitative data synthesis</p><formula xml:id="formula_0">IL-17A (-197G/A) polymorphism</formula><p>The results of the meta-analysis are presented in detail in <ref type="table" target="#tab_5">Table 2</ref>. For the IL-17A (-197G/A) polymorphism, 12 studies were combined. In the overall analysis, a significant association between IL-17A (-197G/A) polymorphism and cancer risk was found under the allele model (OR =1. <ref type="bibr" target="#b22">23</ref>  <ref type="figure" target="#fig_1">Figure 2A</ref>). Therefore, no difference was observed between the cancer types.</p><p>Stratified analyses by the source of control also suggested that IL-17A (-197G/A) polymorphism increased the cancer risk in the population-based control subgroup, under all genetic models (allele model: OR =1. <ref type="bibr" target="#b23">24</ref>  <ref type="figure" target="#fig_1">Figure 2B</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>IL-17F (7488T/C) polymorphism</head><p>For the IL-17F (7488T/C) polymorphism, seven studies were combined. When all seven studies were pooled into the meta-analysis, there was no significant association between   <ref type="figure" target="#fig_2">Figure 3A)</ref>.</p><formula xml:id="formula_1">-17A (-197G/A) IL-17F (7488T/C) IL-17A (-197G/A) (+) IL-17F (7488T/C) (+) PCR-RFLP 0.135; 0.747 Zhang X 32 2013 People's Republic of China Asian Gastric PB 260/512 IL-17A (-197G/A) IL-17F (7488T/C) IL-17A (-197G/A) (+) IL-17F (7488T/C) (-) MassARRAY ® (Sequenom ® ,</formula><p>Next, we performed a subgroup analysis according to the source of controls. The results showed that IL-17F (7488T/C) polymorphism was not associated with cancer risk, in either the population-base control subgroup or the hospital-based control subgroup (all P.0.05) (Table 2 and <ref type="figure" target="#fig_2">Figure 3B</ref>). Therefore, differences in the controls did not affect the association between IL-17F (7488T/C) polymorphism and cancer risk.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Sensitivity analysis</head><p>The sensitivity analysis indicated that no single study influenced the pooled OR value, either for IL-17A (-197G/A) polymorphism or for IL-17F (7488T/C) polymorphism, suggesting that the results of this meta-analysis are stable (data not shown).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Publication bias</head><p>Publication bias of the selected articles was assessed using Begg's funnel plot and Egger's test. The shape of the funnel plot did not show an obvious publication bias for IL-17A (-197G/A) polymorphism or IL-17F (7488T/C) polymorphism ( <ref type="figure" target="#fig_3">Figure 4A and B)</ref>. Similarly, no evidence </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p>Large-sample and unbiased, epidemiological studies of predisposition genes polymorphisms could provide insight to etiology of diseases. However, the findings are generally inconsistent, probably due to some limitation in these </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Odds ratio M-H random, 95% Vl</head><p>Odds ratio M-H random, 95% Cl Weight Zhang X 2013 <ref type="bibr" target="#b31">32</ref> Wu X 2010 <ref type="bibr" target="#b29">30</ref> Total events Subtotal (95% Cl)</p><p>Qinghai Z 2014 <ref type="bibr" target="#b32">33</ref> Zhou B 2012 <ref type="bibr" target="#b30">31</ref> Yuan Y 2012 <ref type="bibr" target="#b33">34</ref> Shibata T 2009 <ref type="bibr" target="#b17">18</ref> Luo Y 2010 <ref type="bibr" target="#b35">36</ref> Arisawa T 2012 <ref type="bibr" target="#b18">19</ref> Wang L 2012 <ref type="bibr" target="#b28">29</ref> Rafiei A 2013 <ref type="bibr" target="#b27">28</ref> Quan Y 2012 <ref type="bibr" target="#b26">27</ref> Chen  <ref type="bibr" target="#b30">31</ref> Yuan Y 2012 <ref type="bibr" target="#b33">34</ref> Wang L 2012 <ref type="bibr" target="#b28">29</ref> Quan Subtotal (95% Cl) Zhang X 2013 <ref type="bibr" target="#b31">32</ref> Wu X 2010 <ref type="bibr" target="#b29">30</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Shibata T 2009 18</head><p>Rafiei A 2013 <ref type="bibr" target="#b27">28</ref> Luo Y 2010 <ref type="bibr" target="#b35">36</ref> Arisawa T 2012 <ref type="bibr" target="#b18">19</ref>  </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study or subgroup</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Odds ratio M-H random, 95% Cl</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>50.8%</head><p>Quan Y 2012 <ref type="bibr" target="#b26">27</ref> Luo Y 2010 <ref type="bibr" target="#b35">36</ref> Shibata T 2009 <ref type="bibr" target="#b17">18</ref> Zhang X 2013 <ref type="bibr" target="#b31">32</ref> Qinghai  studies, such as small sample size, and mix of ethnicities and cancer types. Meta-analysis is considered a powerful tool for combining the contradicting results from different studies to achieve greater statistical power and obtain more reliable results than with a single study. <ref type="bibr" target="#b36">37</ref> In this metaanalysis, we investigated the association between IL-17A (-197G/A) (rs2275913) and IL-17F (7488T/C) (rs763780) and cancer risk. Overall, our study provided evidence that IL-17A (-197G/A) polymorphism was associated with cancer susceptibility. However, no association was detected between IL-17F (7488T/C) polymorphism and cancer susceptibility. Sensitivity analysis and publication bias further strengthened the validity of these results.</p><p>IL-17 family members belong to a distinct category of cytokine and are involved in coordinating local tissue inflammation, through release of proinflammatory and neutrophil-mobilizing cytokines. <ref type="bibr" target="#b19">20</ref> To date, investigation into the function of the IL-17 cytokine family has been extensive, but the majority of the effort has focused on the role of two members, IL-17A and IL-17F. The IL-17A and IL-17F genes are both located at 6p12. In addition, among the IL-17 family, from the alignment of the amino acid sequences, IL-17A and IL-17F have the highest overall amino acid sequence identity and share similar functions in terms of their ability to induce chemokines, which are important in neutrophil recruitment and activation. <ref type="bibr" target="#b30">31</ref> IL-17A and IL-17F cytokines are both expressed by Th17 cells, which mediate chronic inflammation and cancer. <ref type="bibr" target="#b8">9</ref> Although the significance of IL-17A and -17F in the pathogenesis of the cancer has still remained unclear, we hypothesized that both the cytokines may affect the development of chronic inflammation followed by malignancy, coordinately or independently. Over the last several years, many studies have identified a variety of environmental, host immune status, and host genetic factors that play important roles in carcinogenesis. Moreover, Espinoza et al reported that IL-17A (-197G/A) polymorphism influences the response of the IL-17 gene promoter to factors released in response to T cell activation, thus leading to a differential IL-17 production. <ref type="bibr" target="#b37">38</ref> Kawaguchi et al revealed that IL-17F (7488T/C), which causes a His-to-Arg substitution at amino acid 161 (H161R) of IL-17F, lacked the ability to activate the mitogen-activated protein kinase pathway, cytokine production, and chemokine production, and blocked induction of IL-8 expression by wild type IL-17F in in vitro functional experiments. <ref type="bibr" target="#b39">39</ref> Therefore, we evaluated the effect of the polymorphisms of two cytokines on cancer risk. Our investigation suggests that IL-17A (-197G/A), but not IL-17F (7488T/C), contributes to cancer susceptibility.</p><p>Subgroup analyses stratified by source of controls and cancer types were also performed. For IL-17A (-197G/A) polymorphism, a significant increased cancer risk was observed in gastric cancer and other cancers, suggesting that cancer type may not affect cancer susceptibility. Moreover, stratified analysis by source of controls suggested that IL-17A (-197G/A) polymorphism was associated with increased risk of cancer in the population-based control subgroup, but not in the hospital-based control subgroup. This may have been due to some selection biases existing in the hospital-based studies because such controls may have come from a population with a related disease and may not have been representative of the general population. For IL-17F (7488T/C) polymorphism, we found little association between IL-17F (7488T/C) polymorphism and cancer risk in subgroups analysis. This result indicates that the differences in cancer types and sources of controls do not affect cancer susceptibility.</p><p>Several potential limitations of the present meta-analysis should be acknowledged. First, significant heterogeneity was observed in the overall and subgroup analyses. Although two potential sources of the heterogeneity were investigated, including the source of controls and cancer types, neither of them sufficiently explained the between-study heterogeneity. Second, the sample size is not large enough, especially for subgroup analysis. Thus, we do not have adequate power to evaluate the possible association for both polymorphisms, and the observed significant associations in some subgroup analysis may be not accurate. Third, the lack of observations concerning gene-gene and gene-environment interactions could have influenced our results. Fourth, only published studies were included in the meta-analysis, and nonsignificant or negative findings may be unpublished. Hence, some inevitable publication biases might exist in the results.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusion</head><p>In conclusion, our meta-analysis provides evidences that the IL-17A (-197G/A) polymorphism might be associated with cancer risk in the Asian populations, while no evidence suggested a significant association between the IL-17F (7488T/C) polymorphism and cancer risk. However, large-sample studies are warranted to validate our findings, especially in some types of cancer. More studies on gene-gene and gene-environment interactions should also be considered in the future, to obtain a more comprehensive understanding of the association between IL-17 polymorphisms and cancer risk.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>OncoTargets and Therapy</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Publish your work in this journal</head><p>Submit your manuscript here: http://www.dovepress.com/oncotargets-and-therapy-journal OncoTargets and Therapy is an international, peer-reviewed, open access journal focusing on the pathological basis of all cancers, potential targets for therapy and treatment protocols employed to improve the management of cancer patients. The journal also focuses on the impact of management programs and new therapeutic agents and protocols on patient perspectives such as quality of life, adherence and satisfaction. The manuscript management system is completely online and includes a very quick and fair peer-review system, which is all easy to use. Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.</p><p>OncoTargets and Therapy 2014:7</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1</head><label>1</label><figDesc>Flow chart of the literature search and study selection. Abbreviations: IL, interleukin; SNP, single nucleotide polymorphism.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2</head><label>2</label><figDesc>Meta-analysis to evaluate the association between the IL-17A (-197G/A) polymorphism and cancer risk (dominant model: AA + AG vs GG). (A) subgroup analysis by cancer type; (B) subgroup analysis by source of control. Abbreviations: IL, interleukin ; M-H, Mantel-Hanszel; vs, versus.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 3</head><label>3</label><figDesc>Meta-analysis to evaluate the association between the IL-17F (7488T/C) polymorphism and cancer risk (dominant model: CC + CT vs TT). (A) subgroup analysis by cancer type; (B) subgroup analysis by source of control. Abbreviations: CI, confidence interval; IL, interleukin; vs, versus.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 4</head><label>4</label><figDesc>plot with pseudo 95% confidence limits Begg's funnel plot with pseudo 95% confidence limits B Funnel plots of IL-17A (-197G/A) polymorphism and IL-17F (7488T/C) polymorphism in the dominant model. (A) IL-17A (-197G/A) polymorphism; (B) IL-17F (7488T/C) polymorphism. Abbreviations: IL, interleukin; SE, standard error of the mean.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>,</head><label></label><figDesc>95% CI =1.10-1.38, P,0.01), dominant model (OR =1.22, 95% CI =1.08-1.37, P,0.01), recessive model (OR =1.50, 95% CI =1.17-1.93, P,0.01), homozygous comparison (OR =1.62, 95% CI =1.27-2.06, P,0.01), and heterozygous comparison (OR =1.11, 95% CI =1.01-1.21, P=0.03). Subgroup analysis, stratified by cancer type, also suggested a signif icant association between IL-17A (-197G/A) polymorphism and cancer risk in the gastric cancer subgroup, under the allele model (OR =1.22, 95% CI =1.06-1.41, P,0.01), dominant model (OR =1.17, 95% CI =1.02-1.33, P=0.03), recessive model (OR =1.58, 95% CI =1.11-2.24, P,0.01), and homozygous comparison (OR =1.61, 95% CI =1.17-2.23, P,0.01). Moreover, a significant association was observed in the other cancer subgroups, under any of the genetic models (P,0.05)</figDesc><table /><note>(Table 2 and</note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head></head><label></label><figDesc>, 95% CI =1.08-1.41, P,0.01; dominant model: OR =1.21, 95% CI =1.09-1.33, P,0.01; recessive model: OR =1.41, 95% CI =1.08-1.82, P=0.01; homozygous comparison: OR =1.53, 95% CI =1.17-2.01, P,0.01; and heterozygous model: OR =1.15, 95% CI =1.02-1.28, P=0.02). In contrast, a significant association was only found under homozygous comparison (OR =1.65, 95% CI =1.08-2.52, P=0.02) in the hospital-based control subgroup(Table 2 and</figDesc><table /><note></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 1</head><label>1</label><figDesc>Characteristics of studies included in the present meta-analysis</figDesc><table><row><cell>Studies</cell><cell cols="3">Year Country Ethnicity Cancer</cell><cell>Source of</cell><cell>Sample</cell><cell>SNP studied</cell><cell>Conclusion</cell><cell>Genotyping</cell><cell>HWE</cell></row><row><cell></cell><cell></cell><cell></cell><cell>type</cell><cell>controls</cell><cell>size</cell><cell></cell><cell></cell><cell>method</cell><cell></cell></row><row><cell cols="2">Arisawa T 19 2012 Japan</cell><cell>Asian</cell><cell cols="2">Gastric HB</cell><cell>337/587</cell><cell cols="3">IL-17A (-197G/A) IL-17A (-197G/A) (+) PCR-SSCP</cell><cell>0.080</cell></row><row><cell>Quan Y 27</cell><cell>2012 People's</cell><cell>Asian</cell><cell cols="2">Cervical PB</cell><cell>311/463</cell><cell>IL-17A (-197G/A)</cell><cell>IL-17A (-197G/A) (+)</cell><cell>Taqman ® (Applied</cell><cell>0.433;</cell></row><row><cell></cell><cell>Republic</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>IL-17F (7488T/C)</cell><cell>IL-17F (7488T/C) (-)</cell><cell>Biosystems, ABI,</cell><cell>0.064</cell></row><row><cell></cell><cell>of China</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Foster City, CA, USA)</cell><cell></cell></row><row><cell>Rafiei A 28</cell><cell>2013 Iran</cell><cell>Asian</cell><cell cols="2">Gastric PB</cell><cell>161/171</cell><cell cols="3">IL-17A (-197G/A) IL-17A (-197G/A) (+) PCR-RFLP</cell><cell>0.491</cell></row><row><cell cols="2">Shibata T 18 2009 Japan</cell><cell>Asian</cell><cell cols="2">Gastric HB</cell><cell>287/523</cell><cell>IL-17A (-197G/A)</cell><cell>IL-17A (-197G/A) (+)</cell><cell>PCR-SSCP</cell><cell>,0.01;</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>IL-17F (7488T/C)</cell><cell>IL-17F (7488T/C) (-)</cell><cell></cell><cell>0.457</cell></row><row><cell>Wang L 29</cell><cell>2012 People's</cell><cell>Asian</cell><cell>Breast</cell><cell>PB</cell><cell>491/502</cell><cell>IL-17A (-197G/A)</cell><cell>IL-17A (-197G/A) (-)</cell><cell>SNaPshot ®</cell><cell>0.173;</cell></row><row><cell></cell><cell>Republic</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>IL-17F (7488T/C)</cell><cell>IL-17F (7488T/C) (-)</cell><cell>SNP assay</cell><cell>0.775</cell></row><row><cell></cell><cell>of China</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(Applied Biosystems)</cell><cell></cell></row><row><cell>Wu X 30</cell><cell>2010 People's</cell><cell>Asian</cell><cell cols="2">Gastric PB</cell><cell cols="4">1,010/1,500 IL-17A (-197G/A) IL-17A (-197G/A) (-) PCR-RFLP</cell><cell>0.351</cell></row><row><cell></cell><cell>Republic</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>of China</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Yuan Y 34</cell><cell>2012 People's</cell><cell>Asian</cell><cell cols="2">Ovarian HB</cell><cell>92/38</cell><cell cols="3">IL-17A (-197G/A) IL-17A (-197G/A) (-) PCR-RFLP</cell><cell>0.028</cell></row><row><cell></cell><cell>Republic</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>of China</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Zhou B 31</cell><cell>2012 People's</cell><cell>Asian</cell><cell cols="2">Bladder HB</cell><cell>301/446</cell><cell>IL-17A (-197G/A)</cell><cell>IL-17A (-197G/A) (+)</cell><cell>Taqman</cell><cell>0.292;</cell></row><row><cell></cell><cell>Republic</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>IL-17F (7488T/C)</cell><cell>IL-17F (7488T/C) (-)</cell><cell></cell><cell>0.060</cell></row><row><cell></cell><cell>of China</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Chen JJ 35</cell><cell>2010 People's</cell><cell>Asian</cell><cell cols="2">Gastric PB</cell><cell cols="4">1,042/1,090 IL-17A (-197G/A) IL-17A (-197G/A) (-) Taqman</cell><cell>0.967</cell></row><row><cell></cell><cell>Republic</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>of China</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Luo Y 36</cell><cell>2010 People's</cell><cell>Asian</cell><cell cols="2">Gastric HB</cell><cell>24/230</cell><cell>IL</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Republic</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>of China</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head></head><label></label><figDesc>P=0.67; recessive model: OR =1.23, 95% CI =0.87-1.75, P=0.24; homozygous comparison: OR =1.24, 95% CI =0.88-1.76, P=0.22; and heterozygous model: OR =1.03, 95% CI =0.82-1.29, P=0.82).In the stratified analysis by cancer type, only the allele model (OR =1.21, 95% CI =1.01-1.44, P=0.04) displayed a significant association between IL-17F (7488T/C) polymorphism and cancer risk, in the gastric cancer subgroup. No significant association was found, under any genetic models, in the other cancer subgroup (all P.0.05) (Table 2 and</figDesc><table><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>0.057;</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>,0.01</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>San Diego, CA, USA)</cell><cell></cell></row><row><cell>Qinghai Z 33 2014 People's</cell><cell>Asian</cell><cell>Gastric HB</cell><cell>311/611</cell><cell>IL-17A (-197G/A)</cell><cell>IL-17A (-197G/A) (+)</cell><cell>MassARRAY</cell><cell>0.070;</cell></row><row><cell>Republic</cell><cell></cell><cell></cell><cell></cell><cell>IL-17F (7488T/C)</cell><cell>IL-17F (7488T/C) (-)</cell><cell></cell><cell>,0.01</cell></row><row><cell>of China</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note>Notes: (+) denotes there is significant association between IL-17A or IL-17F polymorphism and cancer risk. (-) denotes there is no significant association between IL-17A or IL-17F polymorphism and cancer risk. Abbreviations: HB, hospital-based controls; IL, interleukin; HWE, Hardy-Weinberg equilibrium; PB, population-based controls; PCR, polymerase chain reaction; RFLP, restriction fragment length polymorphism; SNP, single nucleotide polymorphism; SSCP, sequence-specific primers.the IL-17F (7488T/C) polymorphism and cancer suscepti- bility, under all genetic models (allele model: OR =1.06, 95% CI =0.89-1.26, P=0.54; dominant model: OR =1.05, 95% CI =0.85-1.29,</note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head>Table 2 Allele model Dominant model Recessive model Homozygous comparison Heterozygous comparison OR (95% CI) P-value OR (95% CI) P-value OR (95% CI)allele vs G allele AA + AG vs GG AA vs GG + AG AA vs GG AG vs GGallele vs T allele CC + CT vs TT CC vs CT + TT CC vs TT CT vs TT</head><label>2</label><figDesc>Meta-analysis of the IL-17A</figDesc><table><row><cell></cell><cell>P-value</cell><cell>0.03</cell><cell>0.28</cell><cell>0.02</cell><cell>0.02</cell><cell>0.68</cell><cell>0.82</cell><cell>0.19</cell><cell>0.46</cell><cell>0.54</cell><cell>0.85</cell></row><row><cell></cell><cell>OR (95% CI)</cell><cell>1.11 (1.01-1.21)</cell><cell>1.06 (0.95-1.18)</cell><cell>1.24 (1.04-1.48)</cell><cell>1.15 (1.02-1.28)</cell><cell>1.03 (0.89-1.21)</cell><cell>1.03 (0.82-1.29)</cell><cell>1.18 (0.92-1.51)</cell><cell>0.88 (0.62-1.24)</cell><cell>1.06 (0.87-1.30)</cell><cell>1.05 (0.66-1.65)</cell></row><row><cell></cell><cell>P-value</cell><cell>,0.01</cell><cell>,0.01</cell><cell>,0.01</cell><cell>,0.01</cell><cell>0.02</cell><cell>0.22</cell><cell>0.17</cell><cell>0.96</cell><cell>0.32</cell><cell>0.47</cell></row><row><cell></cell><cell>OR (95% CI)</cell><cell>1.62 (1.27-2.06)</cell><cell>1.61 (1.17-2.23)</cell><cell>1.69 (1.23-2.33)</cell><cell>1.53 (1.17-2.01)</cell><cell>1.65 (1.08-2.52)</cell><cell>1.24 (0.88-1.76)</cell><cell>1.33 (0.89-1.98)</cell><cell>1.02 (0.50-2.08)</cell><cell>1.28 (0.79-2.06)</cell><cell>1.21 (0.72-2.01)</cell></row><row><cell>(7488T/C) polymorphism with risk of cancer</cell><cell>P-value</cell><cell>,0.01 1.50 (1.17-1.93) ,0.01</cell><cell>0.03 1.58 (1.11-2.24) 0.01</cell><cell>,0.01 1.42 (1.07-1.89) 0.02</cell><cell>,0.01 1.41 (1.08-1.82) 0.01</cell><cell>0.40 1.52 (0.97-2.38) 0.07</cell><cell>0.67 1.23 (0.87-1.75) 0.24</cell><cell>0.08 1.30 (0.87-1.94) 0.20</cell><cell>0.46 1.04 (0.51-2.13) 0.90</cell><cell>0.37 1.26 (0.78-2.03) 0.35</cell><cell>0.84 1.21 (0.72-2.01) 0.47</cell></row><row><cell>(-197G/A) polymorphism and IL-17F</cell><cell></cell><cell>,0.01 1.22 (1.08-1.37)</cell><cell>,0.01 1.17 (1.02-1.33)</cell><cell>,0.01 1.37 (1.11-1.69)</cell><cell>,0.01 1.21 (1.09-1.33)</cell><cell>0.09 1.12 (0.86-1.47)</cell><cell>0.54 1.05 (0.85-1.29)</cell><cell>0.04 1.20 (0.98-1.48)</cell><cell>0.47 0.89 (0.64-1.22)</cell><cell>0.26 1.09 (0.90-1.32)</cell><cell>0.84 1.04 (0.69-1.58)</cell></row><row><cell></cell><cell></cell><cell>IL-17A A Overall (-197G/A) 1.23 (1.10-1.38)</cell><cell>Gastric cancer 1.22 (1.06-1.41)</cell><cell>Other cancers 1.27 (1.09-1.49)</cell><cell>PB subgroup 1.24 (1.08-1.41)</cell><cell>HB subgroup 1.19 (0.97-1.45)</cell><cell>IL-17F C Overall (7488T/C) 1.06 (0.89-1.26)</cell><cell>Gastric cancer 1.21 (1.01-1.44)</cell><cell>Other cancers 0.91 (0.70-1.18)</cell><cell>PB subgroup 1.10 (0.93-1.30)</cell><cell>HB subgroup 1.04 (0.74-1.44)</cell><cell>of publication bias was observed by Egger's test, for the IL-17A (-197G/A) dominant model (P=0.270) or the IL-17F (7488T/C) dominant model (P=0.250).</cell></row></table><note></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_6"><head>1.2.1 Gastric cancer2.2.2. Hospital-based group</head><label></label><figDesc>Chen JJ 2010 35 Heterogeneity: τ 2 =0.01; χ 2 =11.46, df=7 (P=0.12); l 2 =39% Test for overall effect: Z=3.31 (P= 0.0009) Test for overall effect: Z=3.59 (P=0.0003) Heterogeneity: τ 2 =0.02; χ 2 =18.44, df=11 (P=0.07); l 2 =40% Heterogeneity: τ 2 = 0.00; χ 2 =5.02, df=5 (P=0.41); l 2 =0% Test for overall effect: Z=0.84 (P=0.40) Test for overall effect: Z=3.31 (P=0.0009) Heterogeneity: τ 2 =0.06; χ 2 =13.42, df=5 (P=0.02); l 2 =63%</figDesc><table><row><cell></cell><cell></cell><cell></cell><cell>Decreased risk Increased risk</cell></row><row><cell></cell><cell>14.4%</cell><cell>1.05 (0.87, 1.27)</cell></row><row><cell></cell><cell>8.9%</cell><cell>1.33 (0.98, 1.82)</cell></row><row><cell></cell><cell>5.4%</cell><cell>1.57 (1.01, 2.45)</cell></row><row><cell></cell><cell>10.8%</cell><cell>1.29 (1.00, 1.67)</cell></row><row><cell></cell><cell>12.4%</cell><cell>1.17 (0.94, 1.47)</cell></row><row><cell></cell><cell>9.1%</cell><cell>1.39 (1.03, 1.87)</cell></row><row><cell>Subtotal (95% Cl)</cell><cell>60.9%</cell><cell>1.21 (1.09, 1.35)</cell></row><row><cell>Total events</cell><cell></cell><cell></cell></row><row><cell>Total (95% Cl)</cell><cell>100%</cell><cell>1.22 (1.08, 1.37)</cell></row><row><cell>Total events</cell><cell></cell><cell></cell></row><row><cell cols="3">Heterogeneity: τ 2 =0.02; χ 2 =18.44, df=11 (P=0.60); l 2 =0%</cell><cell>0.1 0.2</cell></row><row><cell></cell><cell></cell><cell></cell><cell>Decreased model</cell><cell>Increased model</cell></row></table><note></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_9"><head>, random, 95% CI Odds ratio M-H, random, 95% CI A Study or subgroup 5.2.1. Population-based group 5.2.2 Hospital-based group</head><label></label><figDesc>=0.00; χ 2 =2.72, df=3 (P=0.44); I 2 =0% Heterogeneity: τ 2 =0.05; χ 2 =6.01, df=2 (P=0.05); I 2 =67% Heterogeneity: τ 2 =0.04; χ 2 =12.84, df=6 (P=0.05): I 2 =53% Test for overall effect: Z=1.73 (P=0.08)</figDesc><table><row><cell cols="3">Odds ratio 2.33 (0.98, 5.54) 1.08 (0.75, 1.54) 1.26 (0.86, 1.86) 1.15 (0.79, 1.67) 1.20 (0.98, 1.48) 1.05 (0.85, 1.29) 0.89 (0.64, 1.22) 0.62 (0.44, 0.88) 1.02 (0.74, 1.40) 1.07 (0.79, 1.44) Test for subgroup differences: Chi 2 =2.44 df=1 (P=0.12). I 2 =58.9% Study or subgroup 4.2.1 Gastric cancer 4.2.2 Other cancers Luo Y 2010 36 4.9% 15.4% 14.4% 14.7% 49.4% 17.0% Quan Y 2012 27 Wang L 2012 29 Zhou B 2012 31 Subtotal (95% CI) Total events Total (95% CI) Total events 100.0% 17.7% 15.8% 50.6% Shibata T 2009 18 Zhang X 2013 32 Qinghai Z 2014 33 Subtotal (95% CI) Total events Heterogeneity: τ 2 Test for overall effect: Z=0.74 (P=0.46) Test for overall effect: Z=0.42 (P=0.67) Weight M-H17.0% 1.02 (0.74, 1.40)</cell><cell>0.1 0.2 Decreased risk Increased risk 0.5 2 5 10 1</cell><cell>A</cell><cell></cell><cell></cell><cell>0.1 0.2</cell><cell>0.5 1</cell><cell>2</cell><cell>5 10</cell></row><row><cell>Wang L 2012 29</cell><cell>17.7%</cell><cell>1.07 (0.79, 1.44)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>14.4% 49.2%</cell><cell>1.26 (0.86, 1.86) 1.09 (0.90, 1.32)</cell><cell></cell><cell>B</cell><cell>Study or subgroup</cell><cell>Weight</cell><cell>Odds ratio M-H random, 95% Cl</cell></row><row><cell></cell><cell>4.9%</cell><cell>2.33 (0.98, 5.54)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>15.4%</cell><cell>1.08 (0.75, 1.54)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Zhou B 2012 31</cell><cell>15.8%</cell><cell>0.62 (0.44, 0.88)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>14.7%</cell><cell>1.15, (0.79, 1.67)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Subtotal (95% CI)</cell><cell></cell><cell>1.04 (0.69, 1.58)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Total events</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Total (95% CI)</cell><cell>100.0%</cell><cell>1.05 (0.85, 1.29)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>9.8%</cell><cell>1.18 (0.89, 1.56)</cell></row><row><cell>Total events</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>1.7%</cell><cell>0.40 (0.17, 0.94)</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>8.9%</cell><cell>1.03 (0.76, 1.40)</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>0.6%</cell><cell>0.37 (0.08, 1.74)</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>8.4%</cell><cell>1.63 (1.19, 2.25)</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>9.7%</cell><cell>1.31 (0.98, 1.74)</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>39.1%</cell><cell>1.12 (0.86, 1.47)</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>0.5</cell><cell>1</cell><cell>2</cell><cell>5 10</cell></row></table><note></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">submit your manuscript | www.dovepress.com Dovepress Dovepress</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Abbreviations: CI, confidence interval; HB, hospital-based controls; IL, interleukin; OR, odds ratio; PB, population-based controls; vs, versus.submit your manuscript | www.dovepress.comDovepress Dovepress</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">OncoTargets and Therapy 2014:7 submit your manuscript | www.dovepress.comDovepress Dovepress</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p>This work has been supported by Grants from the National Natural Science Foundation of China (No 81301835).</p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Disclosure</head><p>The authors report no conflicts of interest in this work.</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Interleukin-17 Family Members and Inflammation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jay</forename><forename type="middle">K</forename><surname>Kolls</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anders</forename><surname>Lindén</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.immuni.2004.08.018</idno>
		<idno type="PMID">15485625</idno>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<title level="j" type="abbrev">Immunity</title>
		<idno type="ISSN">1074-7613</idno>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="467" to="476" />
			<date type="published" when="2004-10" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Laan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><forename type="middle">H</forename><surname>Cui</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Hoshino</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">162</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="2347" to="2352" />
			<date type="published" when="1999" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Requirement of Endogenous Stem Cell Factor and Granulocyte-Colony-Stimulating Factor for IL-17-Mediated Granulopoiesis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Schwarzenberger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Ye</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Oliver</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Manuel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Bagby</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Nelson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">K</forename><surname>Kolls</surname></persName>
		</author>
		<idno type="DOI">10.4049/jimmunol.164.9.4783</idno>
		<idno type="PMID">10779785</idno>
		<ptr type="open-access" target="http://www.jimmunol.org/content/164/9/4783.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Immunology</title>
		<title level="j" type="abbrev">The Journal of Immunology</title>
		<idno type="ISSN">0022-1767</idno>
		<idno type="ISSNe">1550-6606</idno>
		<imprint>
			<biblScope unit="volume">164</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="4783" to="4789" />
			<date type="published" when="2000-05-01" />
			<publisher>The American Association of Immunologists</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Fossiez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><surname>Djossou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Chomarat</surname></persName>
		</author>
		<idno type="DOI">10.1084/jem.183.6.2593</idno>
		<idno type="PMID">8676080</idno>
		<idno type="PMCID">PMC2192621</idno>
		<ptr type="open-access" target="http://jem.rupress.org/content/183/6/2593.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Experimental Medicine</title>
		<title level="j" type="abbrev">Journal of Experimental Medicine</title>
		<idno type="ISSN">0022-1007</idno>
		<idno type="ISSNe">1540-9538</idno>
		<imprint>
			<biblScope unit="volume">183</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="2593" to="2603" />
			<date type="published" when="1996-06-01" />
			<publisher>Rockefeller University Press</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">V</forename><surname>Jovanovic</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Di</forename><surname>Battista</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">A</forename><surname>Martel-Pelletier</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">160</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="3513" to="3521" />
			<date type="published" when="1998" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">NF-kappa B-inducing kinase is a common mediator of IL-17-, TNF-alpha-, and IL-1 betainduced chemokine promoter activation in intestinal epithelial cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Awane</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">G</forename><surname>Andres</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">J</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">C</forename><surname>Reinecker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">162</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="5337" to="5344" />
			<date type="published" when="1999" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Benchetrit</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Ciree</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Vives</surname></persName>
		</author>
		<idno type="DOI">10.1182/blood.v99.6.2114</idno>
		<idno type="PMID">11877287</idno>
		<ptr type="open-access" target="http://www.bloodjournal.org/content/99/6/2114.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<idno type="ISSN">0006-4971</idno>
		<idno type="ISSNe">1528-0020</idno>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="2114" to="2121" />
			<date type="published" when="2002-03-15" />
			<publisher>American Society of Hematology</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Protumor vs Antitumor Functions of IL-17</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Murugaiyan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Saha</surname></persName>
		</author>
		<idno type="DOI">10.4049/jimmunol.0901017</idno>
		<idno type="PMID">19767566</idno>
		<ptr type="open-access" target="http://www.jimmunol.org/content/183/7/4169.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Immunology</title>
		<title level="j" type="abbrev">The Journal of Immunology</title>
		<idno type="ISSN">0022-1767</idno>
		<idno type="ISSNe">1550-6606</idno>
		<imprint>
			<biblScope unit="volume">183</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="4169" to="4175" />
			<date type="published" when="2009-09-18" />
			<publisher>The American Association of Immunologists</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Miyahara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Odunsi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Peng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Matsuzaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R-F</forename><surname>Wang</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.0710686105</idno>
		<idno type="PMID">18832156</idno>
		<idno type="PMCID">PMC2563129</idno>
		<ptr type="open-access" target="http://www.pnas.org/content/105/40/15505.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Proceedings of the National Academy of Sciences</title>
		<title level="j" type="abbrev">Proceedings of the National Academy of Sciences</title>
		<idno type="ISSN">0027-8424</idno>
		<idno type="ISSNe">1091-6490</idno>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="issue">40</biblScope>
			<biblScope unit="page" from="15505" to="15510" />
			<date type="published" when="2008-10-01" />
			<publisher>Proceedings of the National Academy of Sciences</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Breastfeeding: opinion and knowledge of pharmacists. A study in a semi-urban territory</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Schaffar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">S</forename><surname>Huyghe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Bomy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Duriez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Ego</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Pierrat</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Pediatr</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="476" to="483" />
			<date type="published" when="2012" />
			<publisher>French</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xingwu</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lori</forename><forename type="middle">A</forename><surname>Mulcahy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rabab</forename><forename type="middle">Aa</forename><surname>Mohammed</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrew</forename><forename type="middle">Hs</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hester</forename><forename type="middle">A</forename><surname>Franks</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Laura</forename><surname>Kilpatrick</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Acelya</forename><surname>Yilmazer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">Claire</forename><surname>Paish</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ian</forename><forename type="middle">O</forename><surname>Ellis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Poulam</forename><forename type="middle">M</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrew</forename><forename type="middle">M</forename><surname>Jackson</surname></persName>
		</author>
		<idno type="DOI">10.1186/bcr2195</idno>
		<idno type="PMID">19014637</idno>
		<idno type="PMCID">PMC2656888</idno>
		<ptr type="open-access" target="https://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2195" />
	</analytic>
	<monogr>
		<title level="j">Breast Cancer Research</title>
		<title level="j" type="abbrev">Breast Cancer Res</title>
		<idno type="ISSNe">1465-542X</idno>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">95</biblScope>
			<date type="published" when="2008-11-17" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dong-Ming</forename><surname>Kuang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chen</forename><surname>Peng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Qiyi</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yan</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Min-Shan</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Limin</forename><surname>Zheng</surname></persName>
		</author>
		<idno type="DOI">10.1002/hep.23291</idno>
		<idno type="PMID">19902483</idno>
	</analytic>
	<monogr>
		<title level="j">Hepatology</title>
		<title level="j" type="abbrev">Hepatology</title>
		<idno type="ISSN">0270-9139</idno>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="154" to="164" />
			<date type="published" when="2009-09-09" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Mast cells expressing interleukin 17 in the muscularis propria predict a favorable prognosis in esophageal squamous cell carcinoma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bo</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lian</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuan</forename><surname>Liao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jinqing</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xingjuan</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yi</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jing</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Huilan</forename><surname>Rao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shupeng</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lanjun</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Limin</forename><surname>Zheng</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00262-013-1460-4</idno>
		<idno type="PMID">23912243</idno>
		<idno type="ark">ark:/67375/VQC-0QLWPBJ6-P</idno>
		<idno type="istexId">D5BECFC7D250A837552DBC684681B5BA374C2EBE</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Immunology, Immunotherapy</title>
		<title level="j" type="abbrev">Cancer Immunol Immunother</title>
		<idno type="ISSN">0340-7004</idno>
		<idno type="ISSNe">1432-0851</idno>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1575" to="1585" />
			<date type="published" when="2013-08-03" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Expression of interleukin-17 and its clinical significance in gastric cancer patients</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xin</forename><forename type="middle">Ying</forename><surname>Meng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chang</forename><forename type="middle">Hong</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jian</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chen</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ping</forename><surname>Ji</surname></persName>
		</author>
		<idno type="DOI">10.1007/s12032-012-0273-1</idno>
		<idno type="PMID">22744708</idno>
		<idno type="ark">ark:/67375/VQC-LVHW6783-T</idno>
		<idno type="istexId">085A667C4D40271B59DA8AD078175184EE9C5BE9</idno>
	</analytic>
	<monogr>
		<title level="j">Medical Oncology</title>
		<title level="j" type="abbrev">Med Oncol</title>
		<idno type="ISSN">1357-0560</idno>
		<idno type="ISSNe">1559-131X</idno>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="3024" to="3028" />
			<date type="published" when="2012-06-29" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Interleukin-17 may be a valuable serum tumor marker in patients with colorectal carcinoma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Radosavljevic</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Ljujic</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Jovanovic</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><surname>Srzentic</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Pavlovic</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Zdravkovic</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Milovanovic</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Bankovic</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Knezevic</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Acimovic</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Arsenijevic</surname></persName>
		</author>
		<idno type="DOI">10.4149/neo_2010_02_135</idno>
		<idno type="PMID">20099977</idno>
		<ptr type="open-access" target="http://www.elis.sk/download_file.php?product_id=1816&amp;session_id=i3n312hu556mu717pm29mbp0q0" />
	</analytic>
	<monogr>
		<title level="j">Neoplasma</title>
		<title level="j" type="abbrev">neo</title>
		<idno type="ISSN">0028-2685</idno>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="135" to="144" />
			<date type="published" when="2010-01" />
			<publisher>AEPress, s.r.o.</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Endogenous IL-17 contributes to reduced tumor growth and metastasis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Kryczek</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Szeliga</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Vatan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Zou</surname></persName>
		</author>
		<idno type="DOI">10.1182/blood-2008-09-177360</idno>
		<idno type="PMID">19289853</idno>
		<idno type="PMCID">PMC2714210</idno>
		<ptr type="open-access" target="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714210/pdf" />
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<title level="j" type="abbrev">Blood</title>
		<idno type="ISSN">0006-4971</idno>
		<idno type="ISSNe">1528-0020</idno>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="357" to="359" />
			<date type="published" when="2009-03-16" />
			<publisher>American Society of Hematology</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Natalia</forename><surname>Martin-Orozco</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Pawel</forename><surname>Muranski</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yeonseok</forename><surname>Chung</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xuexian</forename><forename type="middle">O</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tomohide</forename><surname>Yamazaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sijie</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Patrick</forename><surname>Hwu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nicholas</forename><forename type="middle">P</forename><surname>Restifo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Willem</forename><forename type="middle">W</forename><surname>Overwijk</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chen</forename><surname>Dong</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.immuni.2009.09.014</idno>
		<idno type="PMID">19879162</idno>
		<idno type="PMCID">PMC2787786</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc2787786?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<title level="j" type="abbrev">Immunity</title>
		<idno type="ISSN">1074-7613</idno>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="787" to="798" />
			<date type="published" when="2009-11" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Genetic polymorphism of interleukin-17A and -17F genes in gastric carcinogenesis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tomoyuki</forename><surname>Shibata</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tomomitsu</forename><surname>Tahara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ichiro</forename><surname>Hirata</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tomiyasu</forename><surname>Arisawa</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.humimm.2009.04.030</idno>
		<idno type="PMID">19414056</idno>
	</analytic>
	<monogr>
		<title level="j">Human Immunology</title>
		<title level="j" type="abbrev">Human Immunology</title>
		<idno type="ISSN">0198-8859</idno>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="547" to="551" />
			<date type="published" when="2009-07" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Influence of IL17A polymorphisms on the aberrant methylation of DAPK and CDH1 in non-cancerous gastric mucosa</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tomiyasu</forename><surname>Arisawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tomomitsu</forename><surname>Tahara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mikihiro</forename><surname>Tsutsumi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tomoyuki</forename><surname>Shibata</surname></persName>
		</author>
		<idno type="DOI">10.1186/1471-2350-13-59</idno>
		<idno type="PMID">22827846</idno>
		<idno type="PMCID">PMC3458965</idno>
		<ptr type="open-access" target="https://bmcmedgenet.biomedcentral.com/track/pdf/10.1186/1471-2350-13-59" />
	</analytic>
	<monogr>
		<title level="j">BMC Medical Genetics</title>
		<title level="j" type="abbrev">BMC Med Genet</title>
		<idno type="ISSNe">1471-2350</idno>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">59</biblScope>
			<date type="published" when="2012-07-24" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">IL-17 cytokine family</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mio</forename><surname>Kawaguchi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mitsuru</forename><surname>Adachi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Naruhito</forename><surname>Oda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fumio</forename><surname>Kokubu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shau-Ku</forename><surname>Huang</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jaci.2004.10.019</idno>
		<idno type="PMID">15577820</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Allergy and Clinical Immunology</title>
		<title level="j" type="abbrev">Journal of Allergy and Clinical Immunology</title>
		<idno type="ISSN">0091-6749</idno>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1265" to="1273" />
			<date type="published" when="2004-12" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note>quiz 1274</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Statistical Power to Detect the Correct Number of Classes in Latent Profile Analysis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jenn-Yun</forename><surname>Tein</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stefany</forename><surname>Coxe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Heining</forename><surname>Cham</surname></persName>
		</author>
		<idno type="DOI">10.1080/10705511.2013.824781</idno>
		<idno type="PMID">24489457</idno>
		<idno type="PMCID">PMC3904803</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc3904803?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Structural Equation Modeling: A Multidisciplinary Journal</title>
		<title level="j" type="abbrev">Structural Equation Modeling: A Multidisciplinary Journal</title>
		<idno type="ISSN">1070-5511</idno>
		<idno type="ISSNe">1532-8007</idno>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="640" to="657" />
			<date type="published" when="2013-10" />
			<publisher>Informa UK Limited</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">A method for meta-analysis of molecular association studies</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ammarin</forename><surname>Thakkinstian</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Patrick</forename><surname>Mcelduff</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Catherine</forename><surname>D'este</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><surname>Duffy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><surname>Attia</surname></persName>
		</author>
		<idno type="DOI">10.1002/sim.2010</idno>
		<idno type="PMID">15568190</idno>
		<idno type="ark">ark:/67375/WNG-SX65M2BD-T</idno>
		<idno type="istexId">136CCD5091FFF37AF4515FCE04D10A9D92CFC76C</idno>
	</analytic>
	<monogr>
		<title level="j">Statistics in Medicine</title>
		<title level="j" type="abbrev">Statist. Med.</title>
		<idno type="ISSN">0277-6715</idno>
		<idno type="ISSNe">1097-0258</idno>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1291" to="1306" />
			<date type="published" when="2005" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Quantifying heterogeneity in a meta-analysis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Julian</forename><forename type="middle">P T</forename><surname>Higgins</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Simon</forename><forename type="middle">G</forename><surname>Thompson</surname></persName>
		</author>
		<idno type="DOI">10.1002/sim.1186</idno>
		<idno type="PMID">12111919</idno>
		<idno type="ark">ark:/67375/WNG-0GZR71QC-D</idno>
		<idno type="istexId">C267E6180EB230A44DF5022BE713652D68802B98</idno>
	</analytic>
	<monogr>
		<title level="j">Statistics in Medicine</title>
		<title level="j" type="abbrev">Statist. Med.</title>
		<idno type="ISSN">0277-6715</idno>
		<idno type="ISSNe">1097-0258</idno>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1539" to="1558" />
			<date type="published" when="2002" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Operating Characteristics of a Rank Correlation Test for Publication Bias</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Colin</forename><forename type="middle">B</forename><surname>Begg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Madhuchhanda</forename><surname>Mazumdar</surname></persName>
		</author>
		<idno type="DOI">10.2307/2533446</idno>
		<idno type="PMID">7786990</idno>
	</analytic>
	<monogr>
		<title level="j">Biometrics</title>
		<title level="j" type="abbrev">Biometrics</title>
		<idno type="ISSN">0006-341X</idno>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">1088</biblScope>
			<date type="published" when="1994-12" />
			<publisher>JSTOR</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Bias in meta-analysis detected by a simple, graphical test</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Egger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">D</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Schneider</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Minder</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.315.7109.629</idno>
		<idno type="PMID">9310563</idno>
		<idno type="PMCID">PMC2127453</idno>
		<idno type="ark">ark:/67375/NVC-GDHS6BZN-G</idno>
		<idno type="istexId">5C725A55ADC81009B0F9838AE28F5EE6633E6FCC</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc2127453?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<title level="j" type="abbrev">BMJ</title>
		<idno type="ISSN">0959-8138</idno>
		<idno type="ISSNe">1468-5833</idno>
		<imprint>
			<biblScope unit="volume">315</biblScope>
			<biblScope unit="issue">7109</biblScope>
			<biblScope unit="page" from="629" to="634" />
			<date type="published" when="1997-09-13" />
			<publisher>BMJ</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Genetic polymorphisms of IL17A and pri-microRNA-938, targeting IL17A 3′-UTR, influence susceptibility to gastric cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tomiyasu</forename><surname>Arisawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tomomitsu</forename><surname>Tahara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hisakazu</forename><surname>Shiroeda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yasuhito</forename><surname>Matsue</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takahiro</forename><surname>Minato</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tomoe</forename><surname>Nomura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hideto</forename><surname>Yamada</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ranji</forename><surname>Hayashi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takashi</forename><surname>Saito</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kazuhiro</forename><surname>Matsunaga</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tomoki</forename><surname>Fukuyama</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nobuhiko</forename><surname>Hayashi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Toshimi</forename><surname>Otsuka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Atsushi</forename><surname>Fukumura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masakatsu</forename><surname>Nakamura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tomoyuki</forename><surname>Shibata</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.humimm.2012.04.011</idno>
		<idno type="PMID">22537748</idno>
	</analytic>
	<monogr>
		<title level="j">Human Immunology</title>
		<title level="j" type="abbrev">Human Immunology</title>
		<idno type="ISSN">0198-8859</idno>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="747" to="752" />
			<date type="published" when="2012-07" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Association betweenIL17Polymorphisms and Risk of Cervical Cancer in Chinese Women</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yi</forename><surname>Quan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bin</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yanyun</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ruiqi</forename><surname>Duan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kana</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Qianqian</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shaoqing</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yaping</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lin</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mingrong</forename><surname>Xi</surname></persName>
		</author>
		<idno type="DOI">10.1155/2012/258293</idno>
		<idno type="PMID">23049595</idno>
		<idno type="PMCID">PMC3463183</idno>
		<ptr type="open-access" target="http://downloads.hindawi.com/journals/jir/2012/258293.pdf" />
	</analytic>
	<monogr>
		<title level="j">Clinical and Developmental Immunology</title>
		<title level="j" type="abbrev">Clinical and Developmental Immunology</title>
		<idno type="ISSN">1740-2522</idno>
		<idno type="ISSNe">1740-2530</idno>
		<imprint>
			<biblScope unit="volume">2012</biblScope>
			<biblScope unit="page" from="1" to="6" />
			<date type="published" when="2012" />
			<publisher>Hindawi Limited</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Polymorphism in the interleukin-17A promoter contributes to gastric cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Raf Iei</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Hosseini</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Janbabai</surname></persName>
		</author>
		<idno type="DOI">10.3748/wjg.v19.i34.5693</idno>
		<idno type="PMID">24039363</idno>
		<idno type="PMCID">PMC3769907</idno>
	</analytic>
	<monogr>
		<title level="j">World Journal of Gastroenterology</title>
		<title level="j" type="abbrev">WJG</title>
		<idno type="ISSN">1007-9327</idno>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">34</biblScope>
			<biblScope unit="page">5693</biblScope>
			<date type="published" when="2013" />
			<publisher>Baishideng Publishing Group Inc.</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Association Analysis of IL-17A and IL-17F Polymorphisms in Chinese Han Women with Breast Cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lihong</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yongdong</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Youxue</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuwen</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sunhui</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zhihua</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Baoling</forename><surname>Tian</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yue</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wei</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Da</forename><surname>Pang</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0034400</idno>
		<idno type="PMID">22461912</idno>
		<idno type="PMCID">PMC3312906</idno>
		<ptr type="open-access" target="https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0034400&amp;type=printable" />
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<title level="j" type="abbrev">PLoS ONE</title>
		<idno type="ISSNe">1932-6203</idno>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">e34400</biblScope>
			<date type="published" when="2012-03-26" />
			<publisher>Public Library of Science (PLoS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Association between polymorphisms in interleukin-17A and interleukin-17F genes and risks of gastric cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiaoqin</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zhirong</forename><surname>Zeng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bin</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jun</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ling</forename><surname>Xue</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuantao</forename><surname>Hao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Minhu</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joseph</forename><forename type="middle">J Y</forename><surname>Sung</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Pinjin</forename><surname>Hu</surname></persName>
		</author>
		<idno type="DOI">10.1002/ijc.25027</idno>
		<idno type="PMID">19904747</idno>
	</analytic>
	<monogr>
		<title level="j">International Journal of Cancer</title>
		<title level="j" type="abbrev">Int. J. Cancer</title>
		<idno type="ISSN">0020-7136</idno>
		<imprint>
			<biblScope unit="volume">127</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="86" to="92" />
			<date type="published" when="2009-11-10" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Interleukin-17 gene polymorphisms are associated with bladder cancer in a chinese han population</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bin</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peng</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yanyun</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shaoqing</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kui</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hong</forename><surname>Liao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lin</forename><surname>Zhang</surname></persName>
		</author>
		<idno type="DOI">10.1002/mc.21928</idno>
		<idno type="PMID">22692973</idno>
		<idno type="ark">ark:/67375/WNG-DL95XGKQ-B</idno>
		<idno type="istexId">6AECCF967C41017E7923A9F97501F85CD9CAAE32</idno>
	</analytic>
	<monogr>
		<title level="j">Molecular Carcinogenesis</title>
		<title level="j" type="abbrev">Mol. Carcinog.</title>
		<idno type="ISSN">0899-1987</idno>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="871" to="878" />
			<date type="published" when="2012-06-12" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Analysis of the association of interleukin-17 gene polymorphisms with gastric cancer risk and interaction with Helicobacter pylori infection in a Chinese population</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xukui</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Luming</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yinggang</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiaoqiao</forename><surname>Zhang</surname></persName>
		</author>
		<idno type="DOI">10.1007/s13277-013-1217-x</idno>
		<idno type="PMID">24218334</idno>
	</analytic>
	<monogr>
		<title level="j">Tumor Biology</title>
		<title level="j" type="abbrev">Tumor Biol.</title>
		<idno type="ISSN">1010-4283</idno>
		<idno type="ISSNe">1423-0380</idno>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="1575" to="1580" />
			<date type="published" when="2013-11-12" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Effect of interleukin-17A and interleukin-17F gene polymorphisms on the risk of gastric cancer in a Chinese population</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zhu</forename><surname>Qinghai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wang</forename><surname>Yanying</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chen</forename><surname>Yunfang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zhang</forename><surname>Xukui</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zhang</forename><surname>Xiaoqiao</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.gene.2013.11.007</idno>
		<idno type="PMID">24315816</idno>
	</analytic>
	<monogr>
		<title level="j">Gene</title>
		<title level="j" type="abbrev">Gene</title>
		<idno type="ISSN">0378-1119</idno>
		<imprint>
			<biblScope unit="volume">537</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="328" to="332" />
			<date type="published" when="2014-03" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Association analysis of IL-17A and IL-17F gene polymorphism with epithelial ovarian cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Yuan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Tao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Hunan Normal University (Medical Science)</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">33</biblScope>
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<monogr>
		<title level="m" type="main">Association Study of Polymorphisms in IL23R and IL17A Genes with the Susceptibility of Gastric Cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">J</forename><surname>Chen</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2010" />
			<pubPlace>Nanjing</pubPlace>
		</imprint>
		<respStmt>
			<orgName>Nanjing Medical University</orgName>
		</respStmt>
	</monogr>
	<note>Master&apos;s thesis</note>
</biblStruct>

<biblStruct xml:id="b35">
	<monogr>
		<title level="m" type="main">Association Analysis of Interleukin-17 Genes&apos; Single Nucleotide Polymorphisms (SNPs) with H. Pylori Infection Associated Gastric Disease in Chinese Population. Chongqing: Third Military Medical University</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Luo</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Meta-analysis of genetic association studies</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marcus</forename><forename type="middle">R</forename><surname>Munafò</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jonathan</forename><surname>Flint</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.tig.2004.06.014</idno>
		<idno type="PMID">15313553</idno>
	</analytic>
	<monogr>
		<title level="j">Trends in Genetics</title>
		<title level="j" type="abbrev">Trends in Genetics</title>
		<idno type="ISSN">0168-9525</idno>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="439" to="444" />
			<date type="published" when="2004-09" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<monogr>
		<title/>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">L</forename><surname>Espinoza</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Takami</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Nakata</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Japan Marrow Donor Program. A genetic variant in the IL-17 promoter is functionally associated with acute graft-versus-host disease after unrelated bone marrow transplantation</title>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page">26229</biblScope>
			<date type="published" when="2011" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">IL-17F sequence variant (His161Arg) is associated with protection against asthma and antagonizes wild-type IL-17F activity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Kawaguchi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Takahashi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Hizawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Suzuki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Matsukura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Kokubu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Maeda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Fukui</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Konno</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Huang</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jaci.2005.12.1346</idno>
		<idno type="PMID">16630936</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Allergy and Clinical Immunology</title>
		<title level="j" type="abbrev">Journal of Allergy and Clinical Immunology</title>
		<idno type="ISSN">0091-6749</idno>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="795" to="801" />
			<date type="published" when="2006-04" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
